In this weeks video, Dr. Brian G.M. Durie compares two trials that treat high-risk smoldering multiple myeloma the CESAR trial and the CENTAURUS trial.
BOTTOM LINE:
The IMFs Black Swan Research Initiative is excited about the CESAR trial and will conduct future trials in hopes of achieving a cure for myeloma.